The UK’s University of Oxford, through its strategic partnership with the Ellison Institute of Technology (EIT), has received research funding of £118 ($159.7) million to launch an ambitious new programme of vaccine research. Led by the Oxford Vaccine Group, the new initiative based in the University – CoI-AI (Correlates of Immunity-Artificial Intelligence) – will combine […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!